Lilly is using the cash generated by its dominant GLP 1 franchise (tirzepatide) to expand aggressively into neuroscience while the obesity and diabetes markets absorb increasing competition
When patients consider using both together, understanding their overlapping and distinct effects becomes essential for safe, effective metabolic support
Can glutathione supplementation lead to white spots on the skin
Tirzepatide, a new glucose-lowering therapy for diabetes, is called a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
Weight isnt the only thing affected
These trials, while originally designed to establish non-inferiority, have consistently revealed a broader cardioprotective signal in several agents, suggesting that the benefits extend beyond glucose control